Innovation Pharmaceuticals Inc (IPIX)

[To infinity and beyond!]

re Kevetrin dosing decisions time frame:

The 11/16 pr and the pr from yest talk about the hopes for K phase 2 ovarian with the clear unmentioned problem of what dose will be given. What is the time frame for the decision, let alone the decision?

Will this await the add on to phase 1 to determine a dose? That could be a yea, or two years. Will it be based on pharmacokinetics alone and can be determined from phase 1?


Highly doubtful, right? If such a leap were possible then why do the add on to phase 1? Or is the add on to get more info on pharmacokinetics PLUS safety info at the more frequent doses?

We keep talkng about K news- but seriously folks, any real K news is in the distant future in all likelihood. The end of phase 1 will tell us nothing we do not already know.

Have the even started any add on patients yet? We woulda heard I think.